We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
-$31.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
0.8 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
4.3 quarters
Top 10 Avg Time Held Equity only
0.8 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
HCP icon
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR icon
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO icon
Marathon Oil Corporation
MRO
+$123M
5
CHX icon
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD icon
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS icon
Discover Financial Services
DFS
+$45.1M
4
SCRM icon
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Miscellaneous 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IOVA icon
576
CALL
Iovance Biotherapeutics
IOVA
$6.62B
– –
-40,000
Closed -$20K –
IP icon
577
International Paper
IP
$17B
– –
-53,760
Closed -$2.1M –
IWM icon
578
CALL
iShares Russell 2000 ETF
IWM
$77.4B
– –
-30,000
Closed -$205K –
KPTI icon
579
CALL
Karyopharm Therapeutics
KPTI
$13.7M
– –
-21,720
Closed -$33.9K –
KRYS icon
580
CALL
Krystal Biotech
KRYS
$9.82B
– –
-12,000
Closed -$133K –
LAMR icon
581
Lamar Advertising Co
LAMR
$14.9B
– –
-1,775
Closed -$212K –
LEGN icon
582
CALL
Legend Biotech
LEGN
$3.62B
– –
-30,000
Closed -$18.5K –
LRMR icon
583
CALL
Larimar Therapeutics
LRMR
$277M
– –
-40,000
Closed -$2K –
M icon
584
PUT
Macy's
M
$5.92B
– –
-60,000
Closed -$60K –
MAC icon
585
Macerich
MAC
$6.31B
– –
-145,775
Closed -$2.51M –
MAT icon
586
CALL
Mattel
MAT
$4.77B
– –
-172,500
Closed -$62.3K –
MCD icon
587
McDonald's
MCD
$166B
– –
-7,500
Closed -$2.11M –
MCHP icon
588
Microchip Technology
MCHP
$41B
– –
-10,000
Closed -$897K –
MDT icon
589
Medtronic
MDT
$113B
– –
-16,702
Closed -$1.46M –
MRUS icon
590
PUT
DELISTED
Merus
MRUS
– –
-20,000
Closed -$50K –
NHI icon
591
National Health Investors
NHI
$3.18B
– –
-6,775
Closed -$426K –
NKTX icon
592
Nkarta
NKTX
$161M
– –
-80,000
Closed -$865K –
NLY icon
593
Annaly Capital Management
NLY
$13.8B
– –
-96,500
Closed -$1.9M –
NOW icon
594
ServiceNow
NOW
$146B
– –
-10,595
Closed -$1.62M –
NSC icon
595
Norfolk Southern
NSC
$71.4B
– –
-69,500
Closed -$17.7M –
NTES icon
596
NetEase
NTES
$79.6B
– –
-19,058
Closed -$1.97M –
NVCR icon
597
CALL
NovoCure
NVCR
$1.7B
– –
-100,000
Closed -$120K –
NVCR icon
598
NovoCure
NVCR
$1.7B
– –
-22,782
Closed -$356K –
NXRT icon
599
NexPoint Residential Trust
NXRT
$494M
– –
-33,550
Closed -$1.08M –
OCUL icon
600
CALL
Ocular Therapeutix
OCUL
$1.66B
– –
-50,000
Closed -$8.75K –
22 23
24
25 26

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.